Bicalutamide-figure-1 (Bicalutamide Figure 1)
This is not readable.*
Bicalutamide Tablet, Film Coated
Product Images NDC 82804-082
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 82804-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Bicalutamide-figure-2 (Bicalutamide Figure 2)
This is a Kaplan-Meier curve illustrating the time to progression for two treatment groups involving antiandrogen therapy. The chart shows the proportion of patients not progressing over different time intervals in days, with one group receiving Bicalutamide plus LHRH-A and the other group receiving Flutamide plus LHRH-A. The curve provides valuable information on the effectiveness and progression outcomes of these treatments.*
Bicalutamide-structure (Bicalutamide Structure)
82804-082-90 (Spl Bicalutamide Tablets)
Description: This text contains information about Bicalutamide 50mg tablets packaged by Proficient Rx LP. Each tablet contains Bicalutamide USP 50 mg and is white to off white, circular, biconvex, film-coated, with "485" debossed on one side. The tablets come in a pack of 90, with Lot #00000 and expiration date. The product is manufactured by Sun Pharmaceutical Industries Limited in India. Store at 20°-25°C and keep out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
